UNASYN

This brand name is authorized in United States. It is also authorized in Austria, Cyprus, Ecuador, Estonia, Hong Kong SAR China, Japan, Lithuania, Nigeria, Poland, Romania, Singapore.

Active ingredients

The drug UNASYN contains one active pharmaceutical ingredient (API):

1	Sultamicillin UNII 2M66QX49ZZ - SULTAMICILLIN TOSYLATE DIHYDRATE
	Sultamicillin is the tosylate salt of the double ester of sulbactam plus ampicillin. Sulbactam is a semisynthetic beta-lactamase inhibitor which, in combination with ampicillin, extends the antibacterial activity of the latter to include some beta-lactamase-producing strains of bacteria that would otherwise be resistant.
	Read more about Sultamicillin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
UNASYN Powder for solution for injection	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01CR04	Sultamicillin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CR Combinations of penicillins, incl. beta-lactamase inhibitors
Discover more medicines within J01CR04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	29567-01-11, 360490612, 360870612
EE	Ravimiamet	1018482, 1018493, 1018886, 1018897, 1814161, 1827660, 1828021, 1848449
HK	Department of Health Drug Office	29807
JP	医薬品医療機器総合機構	6131008C1033, 6131008F1030
LT	Valstybinė vaistų kontrolės tarnyba	1003199, 1003200, 1003987, 1060295
NG	Registered Drug Product Database	04-0554
Switch country to Nigeria in order to find specific presentations of UNASYN
PL	Rejestru Produktów Leczniczych	100068940
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65045001, W65046001
SG	Health Sciences Authority	01948P, 01949P, 01950P, 04892P, 06985P
US	FDA, National Drug Code	0049-0013, 0049-0014, 0049-0024